Suppr超能文献

低补体C4对首发视神经脊髓炎谱系障碍患者临床特征的影响

Effect of Low Complement C4 on Clinical Characteristics of Patients with First-Episode Neuromyelitis Optica Spectrum Disorder.

作者信息

Pan Chunyang, Zhao Yi, Xie Haojie, Zhou Yongyan, Duan Ranran, Li Yanfei, Jia Yanjie, Peng Tao

机构信息

Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China.

出版信息

Neuropsychiatr Dis Treat. 2021 Sep 7;17:2859-2866. doi: 10.2147/NDT.S322789. eCollection 2021.

Abstract

PURPOSE

To describe and compare the clinical features of patients with first-episode neuromyelitis optica spectrum disorder (NMOSD) in a normal complement C4 group and a low complement C4 group, and explore the mechanism by which low complement C4 affects the clinical features of patients with NMOSD.

PATIENTS AND METHODS

We retrospectively analyzed clinical data of 169 aquaporin-4 (AQP4) antibody positive patients with NMOSD from the First Affiliated Hospital of Zhengzhou University from December 2013 to March 2021. Prior to treatment, the blood was drawn for detection, and the patients underwent a 3.0 Tesla MRI examination. A low complement C4 level was defined as a serum complement C4 level <0.14 g/L. Depending on whether the complement C4 level was reduced, it was divided into the normal complement C4 group and low complement C4 group. The basic demographics, clinical manifestations, laboratory examinations, and imaging findings of the two groups were compared.

RESULTS

Among the 169 AQP4 antibody positive patients, 54 were low-complement C4 patients and 115 were normal. There were no significant differences in the demographics, clinical manifestations, treatment options, or admission Expanded Disability Status Scale (EDSS) score between two groups (P > 0.05). The median of discharged EDSS was the same (4 vs 4), but the difference between the two was statistically significant (P = 0.019). Compared with the normal complement C4 group, the blood uric acid level (225 vs 179; P = 0.001) and the C3 level (1.06 vs 0.87, P = 0.000) of the low complement C4 group were significantly lower. The incidence of brainstem lesions in patients with low complement C4 was higher (53.7% vs 33%, P = 0.01).

CONCLUSION

The treatment effect of the first-episode AQP4 antibody positive NMOSD low complement C4 group was poor, the blood-brain barrier was more severely damaged, and the disease changes were likely to involve the brainstem.

摘要

目的

描述和比较正常补体C4组与低补体C4组首次发作的视神经脊髓炎谱系障碍(NMOSD)患者的临床特征,探讨低补体C4影响NMOSD患者临床特征的机制。

患者与方法

回顾性分析2013年12月至2021年3月郑州大学第一附属医院169例水通道蛋白4(AQP4)抗体阳性的NMOSD患者的临床资料。治疗前采血检测,并对患者进行3.0特斯拉MRI检查。低补体C4水平定义为血清补体C4水平<0.14g/L。根据补体C4水平是否降低,分为正常补体C4组和低补体C4组。比较两组的基本人口统计学、临床表现、实验室检查和影像学表现。

结果

169例AQP4抗体阳性患者中,低补体C4患者54例,正常患者115例。两组在人口统计学、临床表现、治疗方案或入院时扩展残疾状态量表(EDSS)评分方面无显著差异(P>0.05)。出院时EDSS中位数相同(4对4),但两组间差异有统计学意义(P=0.019)。与正常补体C4组相比,低补体C4组的血尿酸水平(225对179;P=0.001)和C3水平(1.06对0.87,P=0.000)显著降低。低补体C4患者脑干病变发生率较高(53.7%对33%,P=0.01)。

结论

首次发作的AQP4抗体阳性NMOSD低补体C4组治疗效果差,血脑屏障受损更严重,病情变化可能累及脑干。

相似文献

5
The complement and immunoglobulin levels in NMO patients.视神经脊髓炎患者的补体和免疫球蛋白水平。
Neurol Sci. 2014 Feb;35(2):215-20. doi: 10.1007/s10072-013-1481-y. Epub 2013 Jul 24.
6
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.AQP4-IgG 阳性 NMOSD 和 MOGAD 患者的 C3 和 C4 补体水平。
J Neuroimmunol. 2021 Nov 15;360:577699. doi: 10.1016/j.jneuroim.2021.577699. Epub 2021 Aug 24.

引用本文的文献

1
Complement updates in optic neuritis.视神经炎中的补体更新
Front Neurol. 2025 Mar 26;16:1566771. doi: 10.3389/fneur.2025.1566771. eCollection 2025.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验